Compare ADMA Biologics Inc (ADMA) vs Walmart Stores Inc (WMT) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ADMA Biologics Inc vs Walmart Stores Inc — how do they compare? ADMA Biologics Inc trades at $9.28 (market cap $2.13B), while Walmart Stores Inc trades at $112.95 (market cap $887.64B). The key difference: Walmart Stores Inc is far larger — about 416.7× ADMA Biologics Inc's market cap, and Walmart Stores Inc pays a 0.89% dividend while ADMA Biologics Inc pays none. Which is the better fit depends on your goals.
| ADMA | WMT | |
|---|---|---|
Market Cap | $2.13B | $887.64B |
Sector | Health | Consumer Staples |
52-Week High | $20.38 | $134.20 |
52-Week Low | $7.60 | $94.40 |
Enterprise Value | $2.20B | $951.09B |
Volume | — | 5,675,288 |
Dividend Yield | — | 0.89% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ADMA trades at $9.16, up 2.35% today, with a bullish technical signal from moving averages and oscillators. The company reported strong profitability with a 32.43% net income margin and 43.3% ROE for 2025, though recent EPS results were mixed. Analyst consensus is strongly bullish with an $19.00 price target, but multiple class action lawsuits filed in July 2026 alleging securities fraud create significant near-term uncertainty.
The stock offers substantial upside to analyst targets if legal challenges are resolved favorably, supported by robust fundamentals and projected cash flow growth. Primary risks include the outcome of ongoing litigation and potential reputational damage. Investors should weigh strong financial performance against elevated legal and sentiment risks before establishing a position.
Walmart's stock trades at $110.65, down 1.06% on the day, with a bearish technical signal from moving averages but oversold RSI readings. The company reported strong revenue growth to $681.0B in 2025 and has beaten EPS estimates for three consecutive quarters. Recent news highlights Walmart's AI initiatives and expansion of drone deliveries, while analyst consensus remains strongly bullish with a $141.64 price target.
The outlook is positive given Walmart's consistent earnings beats and strategic investments in technology, though near-term price pressure and competitive threats from Amazon pose risks. The stock offers a compelling entry point for long-term investors seeking defensive exposure with growth potential, supported by solid fundamentals and institutional confidence.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About Walmart Stores Inc
Walmart Inc. operates discount stores, supercenters, and neighborhood markets. The Company offers merchandise such as apparel, house wares, small appliances, electronics, musical instruments, books, home improvement, shoes, jewelry, toddler, games, household essentials, pets, pharmaceutical products, party supplies, and automotive tools. Walmart serves customers worldwide.
Read more on WMT →
